Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically ...
New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
Blackstone Life Sciences ("BXLS") today announced a research and development funding agreement to advance the clinical ...
Debi Weiss thought her fatigue and weakness was a seasonal illness, but her condition quickly worsened.
News-Medical.Net on MSN
Biomimetic platform enhances CAR T therapy for relapsed and refractory leukemia
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric ...
See how microbial cell-free DNA sequencing can predict bloodstream infections in children with leukemia days before symptoms ...
New research into acute myeloid leukemia could change future treatment approaches.
A Korea University research study is claiming to have identified a mechanism that allows leukemia cells to survive despite excessive growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results